0000899243-21-000712.txt : 20210106 0000899243-21-000712.hdr.sgml : 20210106 20210106164630 ACCESSION NUMBER: 0000899243-21-000712 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210104 FILED AS OF DATE: 20210106 DATE AS OF CHANGE: 20210106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Simon Barry J. CENTRAL INDEX KEY: 0001647994 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 21511243 MAIL ADDRESS: STREET 1: 2533 SOUTH COAST HIGHWAY 101 STREET 2: SUITE 210 CITY: CARDIFF-BY-THE-SEA STATE: CA ZIP: 92007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-04 0 0001645460 Cue Biopharma, Inc. CUE 0001647994 Simon Barry J. C/O CUE BIOPHARMA, INC. 21 ERIE STREET CAMBRIDGE MA 02139 1 0 0 0 Stock Option (right to buy) 12.36 2021-01-04 4 A 0 10000 0.00 A 2031-01-03 Common Stock 10000 10000 D Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. This option was granted on January 4, 2021. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date. /s/ Barry Simon by Colin Sandercock, attorney-in-fact 2021-01-06